Skip to Content

Join the 'Avelox' group to help and get support from people like you.

Avelox News

Health Tip: Prevent Antibiotic Resistance

Posted 9 Nov 2016 by Drugs.com

-- Antibiotic resistance applies when bacteria are no longer eliminated by a medicine that's supposed to kill them. Experts blame the problem on improper use of antibiotic medications. Here's what you can do to help, according to the World Health Organization: Only take antibiotics when prescribed by a health professional. Always finish the entire supply of antibiotics. Stopping too soon may allow the bacteria to continue living. Never save antibiotics for later use or use leftover antibiotics, and never share antibiotics with someone else. To help reduce the risk of infection in the first place, wash your hands often, get vaccinations and limit your contact with sick people. Read more

Related support groups: Infections, Amoxicillin, Doxycycline, Bacterial Infection, Cephalexin, Azithromycin, Bactrim, Cipro, Ciprofloxacin, Levaquin, Keflex, Zithromax, Trimethoprim, Sulfamethoxazole, Nitrofurantoin, Erythromycin, Minocycline, Clarithromycin, Bacterial Skin Infection, Levofloxacin

CDC: Too Many Antibiotics Still Being Prescribed in U.S.

Posted 19 Sep 2016 by Drugs.com

MONDAY, Sept. 19, 2016 – Despite growing concerns about creating drug-resistant bacteria, overprescribing of antibiotics in U.S. hospitals didn't drop between 2006 and 2012, according to a new federal report. Over that time period, 55 percent of patients received at least one dose of antibiotics during their hospital stay, whether it was needed or not, researchers from the U.S. Centers for Disease Control and Prevention said. "Antibiotic use remains common, and use of the most powerful antibiotics is rising," said lead researcher James Baggs, a CDC epidemiologist. Although the use of antibiotics remained about the same during the study period, a significant increase was seen in the use of newer antibiotics, Baggs said. "Because inappropriate antibiotic use increases the risk of antibiotic resistance and other side effects, continued monitoring of antibiotic use is critical to future ... Read more

Related support groups: Infections, Amoxicillin, Doxycycline, Bacterial Infection, Bactrim, Cipro, Ciprofloxacin, Augmentin, Levaquin, Trimethoprim, Sulfamethoxazole, Nitrofurantoin, Minocycline, Methicillin-Resistant Staphylococcus Aureus Infection, Bacterial Skin Infection, Levofloxacin, Macrobid, Bactrim DS, Clavulanate, Tetracycline

FDA Medwatch Alert: Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects

Posted 26 Jul 2016 by Drugs.com

ISSUE: FDA approved changes to the labels of fluoroquinolone antibacterial drugs for systemic use (i.e., taken by mouth or by injection). Includes the following currently available fluoroquinolones: Avelox (moxifloxacin) Cipro (ciprofloxacin) Cipro extended-release (ciprofloxacin extended-release) Factive (gemifloxacin) Levaquin (levofloxacin) Ofloxacin (generic brand) These medicines are associated with disabling and potentially permanent side effects of the tendons, muscles, joints, nerves, and central nervous system that can occur together in the same patient. As a result, FDA revised the Boxed Warning, FDA’s strongest warning, to address these serious safety issues. In addition, FDA updated other parts of the drug label including the Warnings and Precautions and Medication Guide sections. FDA has determined that fluoroquinolones should be reserved for use in patients who have no o ... Read more

Related support groups: Urinary Tract Infection, Bacterial Infection, Sinusitis, Cipro, Bronchitis, Ciprofloxacin, Pneumonia, Levaquin, Levofloxacin, Avelox, Ofloxacin, Moxifloxacin, Gemifloxacin, Floxin, Factive, Cipro XR, Anthrax, Cipro IV, Plague, Levaquin Leva-Pak

FDA Updates Warnings for Fluoroquinolone Antibiotics

Posted 26 Jul 2016 by Drugs.com

July 26, 2016 – The U.S. Food and Drug Administration today approved safety labeling changes for a class of antibiotics, called fluoroquinolones, to enhance warnings about their association with disabling and potentially permanent side effects and to limit their use in patients with less serious bacterial infections. “Fluoroquinolones have risks and benefits that should be considered very carefully,” said Edward Cox, M.D., director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research. “It’s important that both health care providers and patients are aware of both the risks and benefits of fluoroquinolones and make an informed decision about their use.” Fluoroquinolones are antibiotics that kill or stop the growth of bacteria. While these drugs are effective in treating serious bacterial infections, an FDA safety review found that both oral and inj ... Read more

Related support groups: Urinary Tract Infection, Bacterial Infection, Sinusitis, Cipro, Bronchitis, Ciprofloxacin, Pneumonia, Levaquin, Levofloxacin, Avelox, Ofloxacin, Moxifloxacin, Gemifloxacin, Floxin, Factive, Cipro XR, Anthrax, Cipro IV, Plague, Levaquin Leva-Pak

FDA Bolsters Warnings About Class of Antibiotics

Posted 26 Jul 2016 by Drugs.com

TUESDAY, July 26, 2016 – The U.S. Food and Drug Administration announced Tuesday that it's strengthening label warnings on a class of antibiotics called fluoroquinolones because the drugs can lead to disabling side effects, including long-term nerve damage and ruptured tendons. The agency also cautioned that these bacteria-fighting drugs – including levofloxacin (Levaquin) and ciprofloxacin (Cipro) – shouldn't be prescribed for sinusitis, chronic bronchitis or simple urinary tract infections unless no other treatments options exist. "Fluoroquinolones have risks and benefits that should be considered very carefully," Dr. Edward Cox said in an FDA news release. He's director of the Office of Antimicrobial Products at the FDA's Center for Drug Evaluation and Research. "It's important that both health care providers and patients are aware of both the risks and benefits of ... Read more

Related support groups: Infections, Urinary Tract Infection, Peripheral Neuropathy, Sinusitis, Bladder Infection, Cipro, Bronchitis, Ciprofloxacin, Levaquin, Kidney Infections, Levofloxacin, Avelox, Myasthenia Gravis, Ofloxacin, Vigamox, Ciprodex, Moxifloxacin, Sinus Symptoms, Gatifloxacin, Norfloxacin

FDA Medwatch Alert: Fluoroquinolone Antibacterial Drugs: Drug Safety Communication - FDA Advises Restricting Use for Certain Uncomplicated Infections

Posted 13 May 2016 by Drugs.com

ISSUE: FDA is advising that the serious side effects associated with fluoroquinolone antibacterial drugs generally outweigh the benefits for patients with sinusitis, bronchitis, and uncomplicated urinary tract infections who have other treatment options. For patients with these conditions, fluoroquinolones should be reserved for those who do not have alternative treatment options. An FDA safety review has shown that fluoroquinolones when used systemically (i.e. tablets, capsules, and injectable) are associated with disabling and potentially permanent serious side effects that can occur together. These side effects can involve the tendons, muscles, joints, nerves, and central nervous system. As a result, FDA is requiring the drug labels and Medication Guides for all fluoroquinolone antibacterial drugs to be updated to reflect this new safety information. FDA is continuing to investigate ... Read more

Related support groups: Urinary Tract Infection, Sinusitis, Cipro, Bronchitis, Ciprofloxacin, Levaquin, Levofloxacin, Avelox, Ofloxacin, Moxifloxacin, Gatifloxacin, Gemifloxacin, Norfloxacin, Factive, Sparfloxacin, Floxin, Nalidixic Acid, Lomefloxacin, Maxaquin, Cipro IV

Too Many People Still Take Unneeded Antibiotics: Study

Posted 3 May 2016 by Drugs.com

TUESDAY, May 3, 2016 – Nearly one-third of the antibiotics prescribed in the United States aren't appropriate for the conditions being treated, a new federal government study shows. "We were able to conclude that at least 30 percent of the antibiotics that are given in doctors' offices, emergency departments and hospital-based clinics are unnecessary, meaning that no antibiotics were needed at all," said lead researcher Dr. Katherine Fleming-Dutra. Such misuse has helped fuel the rise of antibiotic-resistant bacteria, which infect 2 million Americans and kill 23,000 every year, said Fleming-Dutra, a pediatrician and epidemiologist at the U.S. Centers for Disease Control and Prevention. Antibiotics are most misused in the treatment of short-term respiratory conditions, such as colds, bronchitis, sore throats, and sinus and ear infections, the researchers reported. "About half of ... Read more

Related support groups: Infections, Amoxicillin, Doxycycline, Bacterial Infection, Cephalexin, Sinusitis, Azithromycin, Bactrim, Cipro, Ciprofloxacin, Augmentin, Levaquin, Tonsillitis/Pharyngitis, Keflex, Zithromax, Sulfamethoxazole, Erythromycin, Cold Symptoms, Minocycline, Clarithromycin

Drug Makers, Governments Sign Deal to Fight Drug-Resistant Infections

Posted 21 Jan 2016 by Drugs.com

A groundbreaking agreement between the drug industry and governments to work together to fight drug-resistant "superbugs" is expected to be announced Thursday. Under the deal, 74 drug makers, 11 diagnostic test makers, and nine industry groups pledge to work with each other and 16 countries to prevent and improve treatment of drug-resistant infections, the Associated Press reported. These infections are a serious threat to millions of people worldwide and a number of factors contribute to the problem, including overuse of antibiotics, declining drug industry research, and few new medicines to combat bacteria, viruses, parasites and fungi. The new deal – scheduled to be announced at the World Economic Forum in Davos, Switzerland – is the first to outline how the drug industry and governments should team up to prevent more drugs from becoming ineffective, to spur development of new ... Read more

Related support groups: Doxycycline, Cephalexin, Bactrim, Cipro, Ciprofloxacin, Levaquin, Keflex, Sulfamethoxazole, Minocycline, Lamisil, Nystatin, Levofloxacin, Bactrim DS, Terbinafine, Cefdinir, Tetracycline, Avelox, Sulfamethoxazole/Trimethoprim, Cefuroxime, Sulfasalazine

Patients Can Self-Administer IV Antibiotics at Home: Study

Posted 25 Dec 2015 by Drugs.com

THURSDAY, Dec. 24, 2015 – Patients can be taught to safely self-administer long-term intravenous antibiotics at home, without the help of a health care worker, a new study suggests. The finding could have a significant impact on uninsured patients who might otherwise spend weeks in a hospital receiving IV care, according to researchers at the University of Texas Southwestern Medical Center at Dallas. "This really taps into human potential, giving a voice to the uninsured at the same time that it offers an opportunity for enormous cost savings to hospitals," study first author Dr. Kavita Bhavan, assistant professor of internal medicine, said in a medical center news release. Some infections require treatment with IV antibiotics for six weeks or more. Patients with insurance typically go home or to a nursing home and have their antibiotics administered by a home health care worker or ... Read more

Related support groups: Infections, Amoxicillin, Doxycycline, Bacterial Infection, Cephalexin, Azithromycin, Bactrim, Cipro, Ciprofloxacin, Augmentin, Levaquin, Keflex, Zithromax, Trimethoprim, Sulfamethoxazole, Nitrofurantoin, Erythromycin, Minocycline, Clarithromycin, Levofloxacin

Health Tip: Understanding Antibiotics

Posted 9 Dec 2015 by Drugs.com

-- By taking an antibiotic as prescribed, you can get well faster and help prevent germs from becoming resistant to your medication. The U.S. Centers for Disease Control and Prevention offers these antibiotic guidelines: Never skip a dose of antibiotic. Always take it on schedule, as directed. Never stop taking an antibiotic early. Always take the entire prescription, unless your doctor tells you otherwise. Never save any antibiotic medication for a future illness. Never take an antibiotic that was prescribed for another person. Read more

Related support groups: Infections, Amoxicillin, Metronidazole, Doxycycline, Bacterial Infection, Cephalexin, Clindamycin, Azithromycin, Bactrim, Cipro, Ciprofloxacin, Augmentin, Levaquin, Flagyl, Keflex, Zithromax, Valtrex, Trimethoprim, Sulfamethoxazole, Acyclovir

Antibiotics May Not Help After 'Complicated' Appendectomy

Posted 2 Nov 2015 by Drugs.com

MONDAY, Nov. 2, 2015 – Antibiotics may not reduce the risk of infections in patients who undergo what's known as a "complicated" appendix removal, a new study finds. "The traditional teaching is that all patients with complicated appendicitis receive post-operative antibiotics to reduce the risk of wound infection or deep organ space infection," study lead author Dennis Kim, of the Los Angeles Biomedical Research Institute, explained in an institute news release. But is that advisory warranted? To find out, Kim's team tracked five-year outcomes for 410 patients. All of the patients had complicated appendectomies, meaning that their appendix was found to be perforated or gangrenous. About two-thirds of the patients received antibiotics after surgery. Those who received antibiotics had no fewer infections, Kim's team said, and they stayed in hospital an average of one day longer than ... Read more

Related support groups: Amoxicillin, Doxycycline, Cephalexin, Azithromycin, Bactrim, Cipro, Ciprofloxacin, Levaquin, Keflex, Zithromax, Sulfamethoxazole, Erythromycin, Minocycline, Clarithromycin, Levofloxacin, Bactrim DS, Cefdinir, Vancomycin, Tetracycline, Avelox

Better Control of Drug-Resistant Germs Could Save Thousands of Lives: CDC

Posted 4 Aug 2015 by Drugs.com

TUESDAY, Aug. 4, 2015 – An immediate, focused effort to halt the spread of antibiotic-resistant germs could save tens of thousands of lives and prevent hundreds of thousands of new infections over the next five years, a new government report suggests. As many as 37,000 lives could be saved, and 619,000 new infections prevented, if community health departments and health care facilities form tight support networks to quickly identify and address emerging outbreaks of antibiotic-resistant bacteria, said report author Dr. John Jernigan. He directs the Office of HAI (Health care-Associated Infections) Prevention Research and Evaluation at the U.S. Centers for Disease Control and Prevention. "When health care facilities and health departments in a community work together to share information about resistance, and then use that information to guide and target prevention efforts, then we ... Read more

Related support groups: Infections, Amoxicillin, Metronidazole, Doxycycline, Bacterial Infection, Clindamycin, Azithromycin, Bactrim, Cipro, Ciprofloxacin, Augmentin, Levaquin, Flagyl, Zithromax, Trimethoprim, Sulfamethoxazole, Nitrofurantoin, Erythromycin, Minocycline, Clarithromycin

Avelox Approved for Plague

Posted 10 May 2015 by Drugs.com

FRIDAY, May 8, 2015 – Avelox (moxifloxacin) was approved by the U.S. Food and Drug Administration on Friday to treat plague, a rare but deadly bacterial infection that can strike the lungs (pneumonic), blood (septicemic) or lymph nodes (bubonic). Only 1,000 to 2,000 cases are reported worldwide annually, the agency said in a news release. It's spread by the bites of infected fleas, or by contact with infected animals or people. However, the Yersinia pestis bacterium could be released intentionally as a bioterrorism agent. Avelox was approved under rules that allow findings from well-controlled animal studies (in this case, African green monkeys) in instances when it isn't ethical or feasible to conduct trials among humans. The disease is so rare that it wouldn't be possible to conduct adequate trials involving people, the FDA said. Avelox's label carries a boxed warning of the ... Read more

Related support groups: Avelox, Moxifloxacin, Plague, Plague Prophylaxis, Avelox IV

FDA Approves Avelox (moxifloxacin) as Additional Antibacterial Treatment for Plague

Posted 8 May 2015 by Drugs.com

May 8, 2015 - The U.S. Food and Drug Administration today approved Avelox (moxifloxacin) to treat patients with plague, a rare and potentially fatal bacterial infection. The agency approval for plague includes use of the drug for the treatment of pneumonic plague (infection of the lungs), and septicemic plague (infection of the blood). Avelox is also approved for prevention of plague in adult patients. Plague is extremely rare in most parts of the world, including the United States, with 1,000 to 2,000 cases worldwide each year. The three most common forms of plague are bubonic plague (infection of the lymph nodes), pneumonic plague and septicemic plague. “Today’s approval provides an additional therapy for the treatment of plague,” said Edward Cox, M.D., M.P.H, director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research. Plague can be spread ... Read more

Related support groups: Avelox, Moxifloxacin, Plague, Plague Prophylaxis, Avelox IV

Study Casts Doubt on Use of Common Antibiotic for UTIs in Women

Posted 30 Apr 2015 by Drugs.com

THURSDAY, April 30, 2015 – The antibiotic most commonly prescribed for bladder and other urinary tract infections, nitrofurantoin, may not be the most effective option, new research suggests. More than 25 percent of older adults have reduced kidney function, and bladder infections are a common complaint. Doctors often turn to nitrofurantoin to treat these and other urinary tract infections (UTIs), but concerns have been raised about the ability of the drug to reach the urinary tract and target bacteria that causes bladder infections, especially in those with poor kidney function. The new Canadian research was led by Dr. Amit Garg, a nephrologist at Western University in London, Ontario. His team compared the benefits of nitrofurantoin to the effectiveness of other commonly used antibiotics such as ciprofloxacin ("Cipro") and norfloxicin. The study, published recently in the Canadian ... Read more

Related support groups: Urinary Tract Infection, Metronidazole, Bactrim, Bladder Infection, Cipro, Ciprofloxacin, Levaquin, Flagyl, Nitrofurantoin, Kidney Infections, Levofloxacin, Macrobid, Bactrim DS, Avelox, Sulfamethoxazole/Trimethoprim, Xifaxan, Polymyxin B, Prevention of Bladder infection, Septra, Macrodantin

Page 1 2 3 4 Next

Ask a Question

Further Information

Related Condition Support Groups

Bacterial Infection, Bronchitis, Sinusitis, Intraabdominal Infection, Skin Infection, Cutaneous Bacillus anthracis, Pneumonia, Tuberculosis - Active, Plague Prophylaxis, Plague, Skin and Structure Infection

Avelox Patient Information at Drugs.com